Long‐Term miR‐669a Therapy Alleviates Chronic Dilated Cardiomyopathy in Dystrophic Mice

BACKGROUND: Dilated cardiomyopathy (DCM) is a leading cause of chronic morbidity and mortality in muscular dystrophy (MD) patients. Current pharmacological treatments are not yet able to counteract chronic myocardial wastage, thus novel therapies are being intensely explored. MicroRNAs have been imp...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Quattrocelli, Mattia, Crippa, Stefania, Montecchiani, Celeste, Camps, Jordi, Cornaglia, Antonia Icaro, Boldrin, Luisa, Morgan, Jennifer, Calligaro, Alberto, Casasco, Andrea, Orlacchio, Aldo, Gijsbers, Rik, D'Hooge, Jan, Toelen, Jaan, Janssens, Stefan, Sampaolesi, Maurilio
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Ltd 2013
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3828786/
https://ncbi.nlm.nih.gov/pubmed/23963759
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.113.000284
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars